Please login to the form below

Not currently logged in
Email:
Password:

Astellas' Jo Underhill promoted to UK sales and marketing director role

She will head the company’s UK urology and dermatology efforts

Astellas Pharma UK Jo UnderhillAstellas Pharma UK has promoted Jo Underhill from divisional sales manager to sales and marketing director of urology and dermatology.

Reporting to general manager Mike Crooks, Underhill will take up the reins for the launch of several new brands in urology, while also handling the company's portfolio of novel and established dermatology treatments.

Commenting on her appointment, Underhill said: “This a very exciting time for the company as we focus on both maintaining leadership and bringing novel therapies to market that have the potential to transform patients' lives.

“As we all know, the NHS is undergoing considerable changes and is under significant financial constraints, so – more than ever – Astellas' focus remains on satisfying the needs of our stakeholders through carefully conceived strategies with a firm basis on evidence.”

As a qualified nurse, with sales and marketing experience gained at Roche and Schering Plough, Underhill joined Astellas Pharma in 2008 as national sales manager for urology and dermatology.

“In her four years at Astellas, Jo has proven herself and has played an important role in supporting our urology portfolio,” said Astellas Pharma UK's Mike Crooks, who noted that the company had tripled its sales to £300m in the three years to 2012.

He added: “Her arrival into this new role completes our UK management team and - with a series of product launches in planning - we now look forward to maintaining and growing our position across all of our therapy areas.”

6th September 2012

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics